Colorectal cancer (CRC) continues to be a significant global health burden, prompting the need for more effective and targeted therapeutic strategies. Nanoparticle-based drug delivery systems have emerged as a promising approach to address the limitations of conventional chemotherapy, offering enhanced specificity, reduced systemic toxicity, and improved therapeutic outcomes. This paper provides an in-depth review of the current advancements in the application of nanoparticles as vehicles for targeted drug delivery in CRC therapy. It covers a variety of nanoparticle types, including liposomes, polymeric nanoparticles, dendrimers, and mesoporous silica nanoparticles (MSNs), with a focus on their design, functionalization, and mechanisms of action. This review also examines the challenges associated with the clinical translation of these technologies and explores future directions, emphasizing the potential of nanoparticle-based systems to revolutionize CRC treatment.
This paper develops Virtual Speech Therapist (VST), an intelligent agent-based platform that streamlines stuttering assessment and delivers customized therapy planning through automated and adaptive AI-driven workflows. VST integrates state-of-the-art deep learning-based stuttering classification, and multi-agent large language model (LLM) reasoning to support evidence-based clinical decision-making. The VST begins with the acquisition and feature extraction of patient speech samples, followed by robust classification of stuttering types. Building on these outputs, VST initiates an agentic reasoning process in which specialized LLM agents autonomously generate, critique, and iteratively refine individualized therapy plans. A dedicated critic agent evaluates all generated therapy plans to ensure clinical safety, methodological soundness, and alignment with peer-reviewed evidence and established professional guidelines. The resulting output is a comprehensive, patient-specific therapy draft intended for clinician review. Incorporating clinician feedback, the system then produces a finalized therapy plan suitable for patient delivery, thereby maintaining a clinician-in-the-loop paradi
Purpose: Proton therapy provides superior dose conformity compared to photon therapy, but its treatment planning is challenged by sensitivity to anatomical changes, setup/range uncertainties, and computational complexity. This review evaluates the role of artificial intelligence (AI) in improving proton therapy treatment planning. Materials and methods: Recent studies on AI applications in image reconstruction, image registration, dose calculation, plan optimization, and quality assessment were reviewed and summarized by application domain and validation strategy. Results: AI has shown promise in automating contouring, enhancing imaging for dose calculation, predicting dose distributions, and accelerating robust optimization. These methods reduce manual workload, improve efficiency, and support more personalized planning and adaptive planning. Limitations include data scarcity, model generalizability, and clinical integration. Conclusion: AI is emerging as a key enabler of efficient, consistent, and patient-specific proton therapy treatment planning. Addressing challenges in validation and implementation will be essential for its translation into routine clinical practice.
Inspire therapy is an FDA-approved internal neurostimulation treatment for obstructive sleep apnea. However, not all patients respond to this therapy, posing a challenge even for experienced otolaryngologists to determine candidacy. This paper makes the first attempt to leverage both machine learning and deep learning techniques in discerning patient responsiveness to Inspire therapy using medical data and videos captured through Drug-Induced Sleep Endoscopy (DISE), an essential procedure for Inspire therapy. To achieve this, we gathered and annotated three datasets from 127 patients. Two of these datasets comprise endoscopic videos focused on the Base of the Tongue and Velopharynx. The third dataset composes the patient's clinical information. By utilizing these datasets, we benchmarked and compared the performance of six deep learning models and five classical machine learning algorithms. The results demonstrate the potential of employing machine learning and deep learning techniques to determine a patient's eligibility for Inspire therapy, paving the way for future advancements in this field.
In traditional medical practices, music therapy has proven effective in treating various psychological and physiological ailments. Particularly in Eastern traditions, the Five Elements Music Therapy (FEMT), rooted in traditional Chinese medicine, possesses profound cultural significance and unique therapeutic philosophies. With the rapid advancement of Information Technology and Artificial Intelligence, applying these modern technologies to FEMT could enhance the personalization and cultural relevance of the therapy and potentially improve therapeutic outcomes. In this article, we developed a music therapy system for the first time by applying the theory of the five elements in music therapy to practice. This innovative approach integrates advanced Information Technology and Artificial Intelligence with Five-Element Music Therapy (FEMT) to enhance personalized music therapy practices. As traditional music therapy predominantly follows Western methodologies, the unique aspects of Eastern practices, specifically the Five-Element theory from traditional Chinese medicine, should be considered. This system aims to bridge this gap by utilizing computational technologies to provide a more
Combination therapy, a treatment approach that involves two or more monotherapies, is widely considered to enhance therapeutic efficacy across different medical conditions. It was often believed that combination therapy is beneficial because of pharmacological interactions between its component monotherapies. However, through laboratory experiments, pharmacologists have recently noted that the benefits of some combination therapies might be largely driven by varying patient-level responses to their component monotherapies. Without accounting for such patient-level heterogeneity, classical statistical inference frameworks for combination therapy might be inadequate and overly optimistic. In this paper, we introduce a novel and model-free statistical inference framework to complement the classical one and evaluate combination therapy after adjusting for patient-level heterogeneity in responses to monotherapies. We address the non-identifiability and nonlinearity issue inherent in adjustment of patient-level heterogeneity and establish conditions for the (partial) identifiability of the cross-world target parameter. We develop an outcome-based optimal matching scheme to achieve asympt
Stuttering is a varied speech disorder that harms an individual's communication ability. Persons who stutter (PWS) often use speech therapy to cope with their condition. Improving speech recognition systems for people with such non-typical speech or tracking the effectiveness of speech therapy would require systems that can detect dysfluencies while at the same time being able to detect speech techniques acquired in therapy. This paper shows that fine-tuning wav2vec 2.0 [1] for the classification of stuttering on a sizeable English corpus containing stuttered speech, in conjunction with multi-task learning, boosts the effectiveness of the general-purpose wav2vec 2.0 features for detecting stuttering in speech; both within and across languages. We evaluate our method on FluencyBank , [2] and the German therapy-centric Kassel State of Fluency (KSoF) [3] dataset by training Support Vector Machine classifiers using features extracted from the finetuned models for six different stuttering-related event types: blocks, prolongations, sound repetitions, word repetitions, interjections, and - specific to therapy - speech modifications. Using embeddings from the fine-tuned models leads to re
Adaptive therapy (AT) is designed to postpone the emergence of drug resistance by exploiting evolutionary competition among tumor subclones. Most mathematical models of AT assume a binary population structure of drug-sensitive and drug-resistant cells, which neglects the continuous nature of phenotypic plasticity. In this study, we propose a mathematical model that integrates a continuous drug susceptibility index with a probabilistic inheritance function to describe clonal dynamics under therapy. The resulting integro-differential system generalizes traditional two-type competition models and captures both heterogeneity and plasticity of tumor cells. Analytical and numerical studies show that (i) continuous therapy drives rapid expansion of resistant clones, (ii) adaptive therapy maintains long-term tumor control by dynamically regulating sensitive populations, and (iii) high phenotypic plasticity accelerates phenotype switching, leading to earlier tumor relapse following continuous therapy. These results identify critical parameter regimes where adaptive therapy outperforms fixed regimens and highlight the essential role of plasticity in shaping treatment outcomes. The proposed f
Targeted Alpha Therapy (TAT) has emerged as a promising modality for the treatment of various malignancies, leveraging the high linear energy transfer (LET) and short range of alpha particles to selectively irradiate cancer cells while sparing healthy tissue. Monitoring and optimizing TAT delivery is crucial for its clinical success. Hyper-spectral Single Photon Imaging (HSPI) presents a novel and versatile approach for the real-time assessment of TAT in vivo. This study introduces a comprehensive framework for HSPI in TAT, encompassing spectral unmixing, quantitative dosimetry, and spatiotemporal visualization. We report the development of a dedicated HSPI system tailored to alpha-emitting radionuclides, enabling the simultaneous acquisition of high-resolution spectral data and single-photon localization. Utilizing advanced spectral unmixing algorithms, we demonstrate the discrimination of alpha-induced scintillation from background fluorescence, facilitating precise alpha particle tracking with adversarial machine learning.
Radiation therapy is a critical component of cancer treatment. However, the delivery of radiation poses inherent challenges, particularly in minimizing radiation exposure to healthy organs surrounding the tumor site. One significant contributing factor to this challenge is the patient's respiration, which introduces uncertainties in the precise targeting of radiation. Managing these uncertainties during radiotherapy is essential to ensure effective tumor treatment while minimizing the adverse effects on healthy tissues. This research addresses the crucial objective of achieving a balanced dose distribution during radiation therapy under conditions of respiration uncertainty. To tackle this issue, we begin by developing a motion uncertainty model employing probability density functions that characterize breathing motion patterns. This model forms the foundation for our efforts to optimize radiation dose delivery. Next, we employ three bio-inspired optimization techniques: Cuckoo search optimization (CSO), flower pollination algorithm (FPA), and bat search Optimization (BSO). Our research evaluates the dose distribution in Gy on both the tumor and healthy organs by applying these bio
Reminiscence therapy is an inexpensive non-pharmacological therapy commonly used due to its therapeutic value for PwD, as it can be used to promote independence, positive moods and behavior, and improve their quality of life. Caregivers are one of the main pillars in the adoption of digital technologies for reminiscence therapy, as they are responsible for its administration. Despite their comprehensive understanding of the needs and difficulties associated with the therapy, their perspective has not been fully taken into account in the development of existing technological solutions. To inform the design of technological solutions within dementia care, we followed a user-centered design approach through worldwide surveys, follow-up semi-structured interviews, and focus groups. Seven hundred and seven informal and 52 formal caregivers participated in our study. Our findings show that technological solutions must provide mechanisms to carry out the therapy in a simple way, reducing the amount of work for caregivers when preparing and conducting therapy sessions. They should also diversify and personalize the current session (and following ones) based on both the biographical informa
Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-term phase, ranging from months to years. While the short-term response, encompassing the multiphasic kinetics of CAR-T cells, is better understood, the mechanisms underlying the outcomes of the long-term response, characterized by sustained remission, relapse, or disease progression, remain less understood due to limited clinical data. Here, we analyze the long-term dynamics of a previously validated mathematical model of CAR-T cell therapy. We perform a comprehensive stability and bifurcation analysis, examining model equilibria and their dynamics over the entire parameter space. Our results show that therapy failure results from a combination of insufficient CAR-T cell proliferation and increased tumor immunosuppression. By combining different techniques of nonlinear dynamics, we identify Hopf and Bogdanov-Takens bifurcations, which allow to elucidate the mechanisms behind oscillatory remissions and transitions to tumor escape. In particular, rapid expansion of CA
Robot-Assisted Therapy (RAT) has successfully been used in Human Robot Interaction (HRI) research by including social robots in health-care interventions by virtue of their ability to engage human users in both social and emotional dimensions. Robots used for these tasks must be designed with several user groups in mind, including both individuals receiving therapy and care professionals responsible for the treatment. These robots must also be able to perceive their context of use, recognize human actions and intentions, and follow the therapeutic goals to perform meaningful and personalized treatment. Effective interactions require for robots to be capable of coordinated, timely behavior in response to social cues. This means being able to estimate and predict levels of engagement, attention, intentionality and emotional state during human-robot interactions. An additional challenge for social robots in therapy and care is the wide range of needs and conditions the different users can have during their interventions, even if they may share the same pathologies their current requirements and the objectives of their therapies can varied extensively. Therefore, it becomes crucial for
In spite of all advances promoted by information technologies, there are still activities where this technology is not applied for reasons such as being carried out in non-profit organizations or because they have not adapted to this modernization. Until recently, the way to work with mobile devices was either by connecting through a web page with the device's browser, or by downloading an application from the corresponding platform. But lately, technologies are being developed that aim to break with this, as in the case of Progressive Web Applications (PWA). One of the advantages offered by PWA is to access the web page and install it as an application on the device. The purpose of this article is to design a progressive Web application for the support of Storytelling Therapy, one of the novel therapies applied in the field of mental health. In addition to providing a software application to enhance Storytelling Therapy workshops, it is also intended to analyze and verify the advantages of PWA in a real case.
We are in a golden age of progress in artificial intelligence (AI). Radiotherapy, due to its technology-intensive nature as well as direct human-machine interactions, is perfectly suited for benefitting from AI to enhance accuracy and efficiency. Over the past few years, a vast majority of AI research have already been published in the field of photon therapy, while the applications of AI specifically targeted for particle therapy remain scarcely investigated. There are two distinct differences between photon therapy and particle therapy: beam interaction physics (photons vs. charged particles) and beam delivery mode (e.g. IMRT/VMAT vs. pencil beam scanning). As a result, different strategies of AI deployment are required between these two radiotherapy modalities. In this article, we aim to present a comprehensive survey of recent literatures exclusively focusing on AI-powered particle therapy. Six major aspects are included: treatment planning, dose calculation, range and dose verification, image guidance, quality assurance and adaptive replanning. A number of perspectives as well as potential challenges and common pitfalls, are also discussed.
Stuttering is a complex speech disorder that negatively affects an individual's ability to communicate effectively. Persons who stutter (PWS) often suffer considerably under the condition and seek help through therapy. Fluency shaping is a therapy approach where PWSs learn to modify their speech to help them to overcome their stutter. Mastering such speech techniques takes time and practice, even after therapy. Shortly after therapy, success is evaluated highly, but relapse rates are high. To be able to monitor speech behavior over a long time, the ability to detect stuttering events and modifications in speech could help PWSs and speech pathologists to track the level of fluency. Monitoring could create the ability to intervene early by detecting lapses in fluency. To the best of our knowledge, no public dataset is available that contains speech from people who underwent stuttering therapy that changed the style of speaking. This work introduces the Kassel State of Fluency (KSoF), a therapy-based dataset containing over 5500 clips of PWSs. The clips were labeled with six stuttering-related event types: blocks, prolongations, sound repetitions, word repetitions, interjections, and
This paper explores the adaptation and application of i-TED Compton imagers for real-time dosimetry in Boron Neutron Capture Therapy (BNCT). The i-TED array, previously utilized in nuclear astrophysics experiments at CERN, is being optimized for detecting and imaging 478 keV gamma-rays, critical for accurate BNCT dosimetry. Detailed Monte Carlo simulations were used to optimize the i-TED detector configuration and enhance its performance in the challenging radiation environment typical of BNCT. Additionally, advanced 3D image reconstruction algorithms, including a combination of back-projection and List-Mode Maximum Likelihood Expectation Maximization (LM-MLEM), are implemented and validated through simulations. Preliminary experimental tests at the Institut Laue-Langevin (ILL) demonstrate the potential of i-TED in a clinical setting, with ongoing experiments focusing on improving imaging capabilities in realistic BNCT conditions.
We examine two models for hepatitis C viral (HCV) dynamics, one for monotherapy with interferon (IFN) and the other for combination therapy with IFN and ribavirin. Optimal therapy for both the models is determined using the steepest gradient method, by defining an objective functional which minimizes the infected hepatocyte levels, virion population and the side-effects of the drug(s). The optimal therapy for both the models shows an initial period of high efficacy, followed by a gradual decline. The period of high efficacy coincides with a significant decrease in the infected hepatocyte levels as well as viral load, whereas the efficacy drops after liver regeneration through restored hepatocyte levels. The period of high efficacy is not altered significantly when the cost coefficients are varied, as long as the side effects are relatively small. This suggests a higher dependence of the optimal therapy on the model parameters in case of drugs with minimal side effects. We use the Latin hypercube sampling technique to randomly generate a large number of patient scenarios (i.e, model parameter sets) and study the dynamics of each set under the optimal therapy already determined. Resu
In this paper we describe briefly the basic aspects of magnetic resonance therapy, registered as TMR therapy. Clinical studies have shown that application of this therapy significantly accelerates wound healing and, in particular, healing of the diabetic foot disease. To understand the working principle of this therapy, we analyze relevant to it biological effects produced by magnetic fields. Based on these data, we show that there is a hierarchy of the possible physical mechanisms, which can produce such effects. The mutual interplay between the mechanisms can lead to a synergetic outcome delayed in time, which can affect the physiological state of the organism. In particular, we show that soliton mediated charge transport during the redox processes in living organisms is sensitive to magnetic fields, so that such fields can facilitate redox processes in particular, and can stimulate the healing effect of the organism in general. This and other non-thermal resonant mechanisms of the biological effects of magnetic fields are summarized as the working principle of the magnetic resonance therapy. We support our approach by some biological and histological data (both in vitro and in v
In here presented in silico study we suggest a way how to implement the evolutionary principles into anti-cancer therapy design. We hypothesize that instead of its ongoing supervised adaptation, the therapy may be constructed as a self-sustaining evolutionary process in a dynamic fitness landscape established implicitly by evolving cancer cells, microenvironment and the therapy itself. For these purposes, we replace a unified therapy with the `therapy species', which is a population of heterogeneous elementary therapies, and propose a way how to turn the toxicity of the elementary therapy into its fitness in a way conforming to evolutionary causation. As a result, not only the therapies govern the evolution of different cell phenotypes, but the cells' resistances govern the evolution of the therapies as well. We illustrate the approach by the minimalistic ad hoc evolutionary model. Its results indicate that the resistant cells could bias the evolution towards more toxic elementary therapies by inhibiting the less toxic ones. As the evolutionary causation of cancer drug resistance has been intensively studied for a few decades, we refer to cancer as a special case to illustrate pure